MSA
ANIP icon

Mason Street Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Mason Street Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,592
Closed -$104K – 88
2020
Q4 		$104K Sell
3,592
-9
-0.2% -$258 ﹤0.01% 1484
2020
Q3 		$102K Buy
3,601
+37
+1% +$1.1K ﹤0.01% 1454
2020
Q2 		$115K Buy
3,564
+324
+10% +$11.6K ﹤0.01% 1436
2020
Q1 		$132K Hold
3,240
– – ﹤0.01% 1365
2019
Q4 		$200K Buy
3,240
+83
+3% +$5.5K ﹤0.01% 1383
2019
Q3 		$230K Buy
3,157
+344
+12% +$25.7K ﹤0.01% 1338
2019
Q2 		$231K Buy
2,813
+149
+6% +$10.6K ﹤0.01% 1331
2019
Q1 		$188K Buy
2,664
+89
+3% +$5.24K ﹤0.01% 1417
2018
Q4 		$116K Buy
2,575
+124
+5% +$6.5K ﹤0.01% 1433
2018
Q3 		$139K Sell
2,451
-170
-6% -$10.4K ﹤0.01% 1450
2018
Q2 		$175K Buy
2,621
+135
+5% +$8.43K ﹤0.01% 1406
2018
Q1 		$145K Buy
2,486
+155
+7% +$9.84K ﹤0.01% 1408
2017
Q4 		$150K Buy
2,331
+61
+3% +$3.79K ﹤0.01% 1398
2017
Q3 		$119K Buy
2,270
+290
+15% +$13.8K ﹤0.01% 1429
2017
Q2 		$93K Buy
1,980
+122
+7% +$5.88K ﹤0.01% 1456
2017
Q1 		$92K Buy
1,858
+112
+6% +$6.29K ﹤0.01% 1447
2016
Q4 		$106K Buy
1,746
+110
+7% +$6.73K ﹤0.01% 1420
2016
Q3 		$109K Buy
1,636
+153
+10% +$9.57K ﹤0.01% 1369
2016
Q2 		$83K Buy
1,483
+140
+10% +$6.81K ﹤0.01% 1394
2016
Q1 		$45K Buy
1,343
+121
+10% +$4.1K ﹤0.01% 1467
2015
Q4 		$55K Buy
1,222
+109
+10% +$4.69K ﹤0.01% 1422
2015
Q3 		$44K Sell
1,113
-22
-2% -$1.25K ﹤0.01% 1447
2015
Q2 		$70K Buy
1,135
+46
+4% +$2.74K ﹤0.01% 1388
2015
Q1 		$68K Buy
+1,089
New +$66.2K ﹤0.01% 1393

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ICOM
Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $486M AUM 50.29% 1-Year Est. Return

Mason Street Advisors's ANIP Position: Q1 2021 in Review

Mason Street Advisors sold out of ANI Pharmaceuticals (ANIP) in Q1 2021, closing a stake of 3,592 shares — an estimated $104K sold.

Mason Street Advisors first reported a position in ANIP in Q1 2015 and held it in 24 quarters. The position peaked at $231K in Q2 2019. 106 funds tracked by Wall St. Rank hold ANIP as of Q1 2021.

  • Mason Street Advisors reported no remaining ANI Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Mason Street Advisors sold 3,592 ANI Pharmaceuticals shares in Q1 2021, an estimated $104K.
  • Mason Street Advisors first reported a position in ANI Pharmaceuticals in Q1 2015 and held it in 24 quarters.
  • Mason Street Advisors's ANI Pharmaceuticals position peaked at $231K in Q2 2019.
  • 106 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2021.

Based on Mason Street Advisors's 13F filing for Q1 2021, filed 14 May 2021.